Key points are not available for this paper at this time.
Metabolic syndrome (MetS) and diabetes mellitus (DM) are frequent in schizophrenia (SCZ) and have been linked to cognitive impairment and low-grade inflammation. In this cross-sectional study of adults with DSM-5 SCZ (N = 218; SCZ = 103, SCZ+MetS = 62, SCZ + DM = 53), we quantified interleukine-6 (IL-6) and C-Reactive Protein (CRP) and evaluated their associations with Repeatable Battery for the Assessment of Neuropsychological Status (RBANS) cognitive domains and routine metabolic measures using multivariable models. Results revealed that SCZ + DM showed lower attention and delayed memory scores than SCZ and SCZ+MetS. No between-group differences were observed for immediate memory, visuospatial function, or language. IL-6 was highest in SCZ + DM, intermediate in SCZ + MetS, and lowest in SCZ. CRP did not differ significantly between groups. Across the cohort, higher IL-6 and fasting glucose were associated with lower attention and delayed memory. We conclude that DM status and higher IL-6 were most consistently associated with poorer attention and delayed memory in SCZ. Given the cross-sectional design, these findings reflect associations and may be influenced by treatment and residual confounding. Longitudinal studies with broader cytokine panels are warranted.
Kancsev et al. (Tue,) studied this question.